Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ektebin
2. Peteha
3. Prothionamide
1. Prothionamide
2. 14222-60-7
3. 2-propylpyridine-4-carbothioamide
4. Ektebin
5. Protionamid
6. Trevintix
7. 2-propylthioisonicotinamide
8. Peteha
9. 2-propyl-thioisonicotinamide
10. Tuberex
11. Protionamidum
12. Protionizina
13. Tebeform
14. 2-propylisonicotinylthioamide
15. 4-pyridinecarbothioamide, 2-propyl-
16. Th-1321
17. 2-propyl-4-pyridinecarbothioamide
18. Rp 9778
19. 2-propyl-4-thiocarbamoylpyridine
20. Isonicotinamide, 2-propylthio-
21. 9778 R.p.
22. 1321 Th
23. Rp-9778
24. Protionamide (inn)
25. Prothionamidum
26. Nsc-758962
27. Protionamide (prothionamide)
28. Mls000042521
29. Protionamida
30. 76yoo33643
31. Ncgc00095164-01
32. Smr000047660
33. Protionamide 100 Microg/ml In Acetonitrile
34. Protionamide [inn]
35. Dsstox_cid_25940
36. Dsstox_rid_81238
37. Dsstox_gsid_45940
38. Protionamidum [inn-latin]
39. Protionamida [inn-spanish]
40. Trevintix (tn)
41. Cas-14222-60-7
42. Th 1321
43. Sr-05000001518
44. Einecs 238-093-7
45. Brn 0118164
46. Protion
47. Protionamide [inn:ban:dcf]
48. Unii-76yoo33643
49. Prothionamide (jp17)
50. Opera_id_999
51. Spectrum2_000019
52. Spectrum3_001964
53. Protionamide [mi]
54. Prothionamide [jan]
55. Schembl74572
56. Bspbio_003564
57. Protionamide [mart.]
58. 5-22-02-00376 (beilstein Handbook Reference)
59. Mls001201789
60. Mls006011877
61. Protionamide [who-dd]
62. Protionamide [who-ip]
63. Spectrum1505316
64. Spbio_000057
65. Chembl1378024
66. Dtxsid7045940
67. Chebi:32066
68. Kbio3_002911
69. Prothionamide, >=99% (hplc)
70. 2-propyl-4-thiocarbamoyl Pyridine
71. Hms1922d06
72. Hms2090j11
73. Hms2235m12
74. Hms3372k04
75. Hms3655o18
76. Hms3715g13
77. Kuc109576n
78. Pharmakon1600-01505316
79. Albb-010476
80. Bcp13522
81. Hy-b0306
82. Ksc-27-052d
83. Zinc3874803
84. Tox21_111463
85. Bbl010291
86. Bdbm50499814
87. Ccg-40049
88. Mfcd00464119
89. Nsc758962
90. Protionamidum [who-ip Latin]
91. S1881
92. Stk366469
93. Stl454225
94. Akos005172678
95. Tox21_111463_1
96. 1321-th
97. Ac-4518
98. Db12667
99. Ks-1282
100. Nsc 758962
101. 2-propylpyridine-4-carbimidothioic Acid
102. Ncgc00095164-02
103. Ncgc00095164-03
104. Ncgc00095164-04
105. Ncgc00095164-05
106. Sbi-0207058.p001
107. Db-042615
108. Ft-0630412
109. P2302
110. Sw199462-2
111. D01195
112. D88012
113. Ab00393463-12
114. Ab01093435-02
115. Ab01093435_03
116. Ab01093435_04
117. A807874
118. Q866657
119. Q-201638
120. Sr-05000001518-1
121. Sr-05000001518-2
122. Sr-05000001518-3
123. Brd-k75360161-001-09-9
| Molecular Weight | 180.27 g/mol |
|---|---|
| Molecular Formula | C9H12N2S |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 180.07211956 g/mol |
| Monoisotopic Mass | 180.07211956 g/mol |
| Topological Polar Surface Area | 71 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 159 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
J - Antiinfectives for systemic use
J04 - Antimycobacterials
J04A - Drugs for treatment of tuberculosis
J04AD - Thiocarbamide derivatives
J04AD01 - Protionamide
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Prothionamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prothionamide, including repackagers and relabelers. The FDA regulates Prothionamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prothionamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prothionamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prothionamide supplier is an individual or a company that provides Prothionamide active pharmaceutical ingredient (API) or Prothionamide finished formulations upon request. The Prothionamide suppliers may include Prothionamide API manufacturers, exporters, distributors and traders.
click here to find a list of Prothionamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Prothionamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prothionamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prothionamide GMP manufacturer or Prothionamide GMP API supplier for your needs.
A Prothionamide CoA (Certificate of Analysis) is a formal document that attests to Prothionamide's compliance with Prothionamide specifications and serves as a tool for batch-level quality control.
Prothionamide CoA mostly includes findings from lab analyses of a specific batch. For each Prothionamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prothionamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Prothionamide EP), Prothionamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prothionamide USP).
LOOKING FOR A SUPPLIER?
